Attovia Therapeutics, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Attovia Therapeutics, Inc. (ATTO) is 9.39

According to Attovia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.39. This represents a change of 60.92% compared to the average of 5.83 of the last 4 quarters.

Attovia Therapeutics, Inc. (ATTO) Historical Current Ratio (quarterly & annually)

How has ATTO Current Ratio performed in the past?

The mean historical Current Ratio of Attovia Therapeutics, Inc. over the last ten years is 11.79. The current 9.39 Current Ratio has changed -20.41% with respect to the historical average. Over the past ten years (40 quarters), ATTO's Current Ratio was at its highest in in the March 2026 quarter at 13.94. The Current Ratio was at its lowest in in the March 2025 quarter at 0.

Attovia Therapeutics, Inc. (ATTO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Attovia Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Attovia Therapeutics, Inc. (ATTO) Average Current Ratio

How has ATTO Current Ratio performed in the past?

The current Current Ratio of Attovia Therapeutics, Inc. (ATTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Attovia Therapeutics, Inc. (ATTO) Current Ratio vs. Peers

How is ATTO’s Current Ratio compared to its peers?

Attovia Therapeutics, Inc.’s Current Ratio is less than MoonLake Immunotherapeutics (12.56), greater than AnaptysBio, Inc. (5.61), greater than Connect Biopharma Holdings Limited (2.37), greater than Aclaris Therapeutics, Inc. (3.46), less than Zura Bio Limited (11.29), less than Evommune, Inc. (11.68), less than Q32 Bio Inc. (20.30), less than AgomAb Therapeutics N.V. American Depositary Shares (12.88), less than Oruka Therapeutics, Inc. (38.51), greater than Alumis Inc. (6.74),

Build a custom stock screener for Attovia Therapeutics, Inc. (ATTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Attovia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Attovia Therapeutics, Inc. (ATTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Attovia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.